Table 3.
Nm23 expression in human carcinoma cohort studies
| Tumor type | Cohort size | Reference |
|---|---|---|
| Inverse correlation between Nm23 expression and metastasis | ||
| Breast cancer | 27 | [99] |
| Breast cancer | 71 | [100] |
| Breast cancer | 168 | [101] |
| Breast cancer | 390 | [102] |
| Breast cancer | 163 | [103] |
| Breast cancer | 130 | [104] |
| Breast cancer | 128 | [105] |
| Breast cancer | 73 | [106] |
| Melanoma | 30 | [107] |
| Melanoma | 157 | [108] |
| Melanoma | 21 | [109] |
| Melanoma | 32 | [110] |
| Melanoma | 120 | [111] |
| Prostate cancer | 346 | [112] |
| Ovarian carcinoma | 50 | [113] |
| Gastric cancer | 24 | [114] |
| Gastric cancer | 59 | [36] |
| Gastric cancer | 413 | [34] |
| Hepatocellular carcinoma | 21 | [115] |
| Hepatocellular carcinoma | 47 | [116] |
| Hepatocellular carcinoma | 43 | [117] |
| Non-small-cell lung cancer | 381 | [118] |
| Non-small-cell lung cancer | 104 | [119] |
| Non-small-cell lung cancer | 285 | [120] |
| Oral squamous cell carcinoma | 86 | [121] |
| Positive correlation between Nm23 expression and metastasis | ||
| Neuroblastoma | 76 | [43] |
| Osteosarcoma | 25 | [44] |
| Non-small-cell lung carcinoma | 36 | [122] |
| Myelogenous leukemia | 110 | [123] |
| Peripheral T-cell lymphoma | 137 | [124] |
| Peripheral T-cell lymphoma | 102 | [125] |
| Lymphomas | 606 | [126] |
| Diffuse large B-cell lymphoma | 172 | [126] |
| Hodgkin lymphoma | 128 | [127] |
| Acute myelogenous leukemia | 102 | [49] |
| Thyroid carcinomas | 86 | [128] |